Members-only Site   |   Print Page   |   Contact Us   |   Sign In   |   Register
News & Press: Breaking News

IACP Submits Comments on FDA's Underestimated Time & Cost Burden of Reporting 503B Adverse Events

Wednesday, September 2, 2015   (0 Comments)
Posted by: Dagmar Anderson
Share |




September 2, 2015


This afternoon, the International Academy of Compounding Pharmacists (IACP) submitted comments on the Food & Drug Administration's (FDA) underestimated time and cost burden of reporting adverse events by 503B outsourcing facilities.


Please click here to read our filing.

Association Management Software Powered by YourMembership  ::  Legal